Together with Phacilitate we developed a survey with over 30 cell and gene therapy professionals to find out what the prominent challenges are with regards to raw materials and how the industry is approaching automation of raw material processes. This article presents the results as well as some perspectives from Bluebird Bio, Cellex Cell Professionals and others.
Read the article & view the infographic